Regulatable CAR platforms could circumvent toxicities associated with CAR-T therapy, but
existing systems have shortcomings including leakiness and attenuated activity. Here, we …

In recent years, the landscape in clinical trial development has changed to involve many
molecularly targeted agents, immunotherapies, or radiotherapy, as a single agent or in …

With decades of progress in medical research and advance in understanding the biology of
cancer microenvironment, clinical development of novel cancer drugs including …